In addition, treatment with BAPN to inhibit LOXL4 enzyme activity resulted in a significant decrease in breast tumour size and weight, while the suppression of LOXL4 gene expression through miRNA markedly reduced the proliferation, migration, and lung metastasis of breast cancer cells both in vitro and in vivo71. This evidence concerns the gene LOXL4 and breast carcinoma.